Maheshwary, N. (2016) “EFFICACY AND COST EFFECTIVENESS OF BIOSIMILAR PEGYLATED INTERFERON α2a 180 µg/RIBAVIRIN IN NON-CIRRHOTIC TREATMENT NAÏVE GENOTYPE 3 PATIENTS”, Pakistan Journal of Physiology, 12(1), pp. 26–28. doi: 10.69656/pjp.v12i1.420.